Tech Company Financing Transactions

eFFECTOR Therapeutics Funding Round

eFFECTOR Therapeutics secured a $4.2 million funding round on 9/30/2014. Investors included Abingworth, Novartis Venture Fund and SR One Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

11180 Roselle St.
San Diego, CA 92121
USA

Phone

(858) 925-8215

Website

www.effector.com

Email Address

[email protected]

Overview

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Steve Worland

        

Chief Financial Officer

Alana McNulty

        

VP - R & D

Siegfried Reich

        

Browse more venture capital transactions:

Prev: 9/30/2014: HapYak venture capital transaction
Next: 9/30/2014: Food52 venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. All VC database entries on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary